Ingredion Incorporated

Fundamentals8.0
Price Action6.0
News Sentiment7.0
AI Rating
7.0

Key Drivers

  • Strong margins
  • Robust cashflow
  • Elevated working capital

AI
AI Summary

7.0

Ingredion is transitioning from a cyclical, commodity‑adjacent supplier into a higher‑margin, solutions‑led business—shifting the earnings mix toward more durable margins and cash generation but only if management executes commercialization and margin capture. Watch upcoming quarters for sustained gross margins >25%, inventory/Argo stabilization, and protein/isolate revenue cadence as the decisive signals that justify re-rating; a miss would validate the market's caution.

SolutionsPivot
ExecutionRisk
CashResilience‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • Strong margins
  • Robust cashflow
  • Elevated working capital

Ingredion combines strong profitability, cash generation and low multiples with moderate leverage and shareholder returns, but elevated inventories/receivables, higher capex and sizable OCI/intangibles warrant monitoring.

SolidFundamentals
WatchWorkingCapital

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below short-term SMA
  • Lower highs/lows
  • Orderly decline

Over the last month the stock slid from about $117 to $109 (mid-single-digit decline), trading meaningfully below its ~$114 short-term SMA with support near $109–$110 and resistance around $117–$120, indicating short-term bearish momentum but an orderly decline that leaves room for a mean-reversion bounce. #mean-reversion‍

bearish
Support Level: $109–$110
Resistance Level: $117–$120

Decline was orderly without sharp spikes, reducing immediate volatility risk

Sentiment & News

7.0

Key News Insights:

  • Institutional accumulation
  • Insider selling
  • Strategic partnerships

Institutional buying, new pharma and AI partnerships, a maintained dividend and ethical recognition contrast with insider sales and a consensus "Hold," pointing to neutral-but-constructive momentum for Ingredion.

Growth
Hold

The mix of external buying, dividend stability and innovation deals offsets insider sales and neutral analyst sentiment, suggesting sideways-to-positive pressure on Ingredion shares